Table 2.
Characteristics | Types | Study |
---|---|---|
Participants | Elite athletes | [12,14,23] |
Well-trained athletes | [15,22] | |
No regular training before the study | [17,24] | |
Supplementation product | Manufactured | [17,24] |
Registered product® | [12,14,15,22,23] | |
% Saponins of the supplementation product | 100% | [22,23,24] |
60% | [14] | |
>40% | [15,17] | |
40% | [12] | |
Total dose (mg) × day−1 | 1875 | [22] |
1800–2700 | [23] | |
1250 | [12] | |
900–1800 | [24] | |
770 | [15] | |
500 | [17] | |
450 | [14] | |
Duration | 12 weeks | [24] |
6 weeks | [15] | |
5 weeks | [14] | |
4 weeks | [23] | |
3 weeks–4 weeks (rest)–3 weeks | [12] | |
2 weeks | [17] | |
20 days | [22] | |
Dose schedule | After exercise and before going to sleep | [23] |
a.m. | [12] | |
a.m. and before going to sleep | [24] | |
a.m. and p.m. | [17,22] | |
No reported | [14,15] |
Abbreviations: a.m. = ante meridiem; p.m. = post meridiem.